Cancer vaccine test results 100 percent successful-Russia claims, now it is ready for use
Russia has successfully completed trials of an mRNA-based cancer vaccine 'Antromix', which has been found effective against cancers such as colon, glioblastoma and melanoma; if approved, it would be the world's first personalized mRNA cancer vaccine and could revolutionize oncology treatment worldwide.